Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FKMXR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,640
Award facts
- Contract value 100% obligated
- $5,639.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,639.94 delivery order on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. The contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply requirements for federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for Ozempic, a diabetes medication, exemplifies the type of brand-name pharmaceutical products the company routinely provides through its federal contract vehicles to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FKMXR?
SPE2DB25FKMXR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FKMXR worth?
The government has obligated $5,640 on SPE2DB25FKMXR.
Is contract SPE2DB25FKMXR an order under another contract?
Yes. SPE2DB25FKMXR is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMXR competed?
The extent of competition for SPE2DB25FKMXR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award